The safety assessment process--setting the scene: an FDA perspective

Area of Science:

• Regulatory Science
• Toxicology
• Public Health

Background:

• FDA's product safety evaluation evolved from scientific research and historical events.
• The Federal Food, Drug, and Cosmetic Act provides FDA's regulatory authority, amended to cover more products and requirements.
• The FDA's structure supports oversight, industry guidance, and research.

Purpose of the Study:

• To describe the evolution and science-based approach of the FDA's product safety evaluation process.
• To highlight the FDA's role in advancing testing strategies and alternative methods.
• To discuss the impact of scientific advancements on toxicological practices.

Main Methods:

• Review of historical events and scientific achievements influencing FDA regulations.
• Analysis of the Federal Food, Drug, and Cosmetic Act and its amendments.
• Examination of FDA's organizational structure and research initiatives.
• Assessment of FDA's participation in national and international scientific collaborations.
• Evaluation of the agency's advocacy for alternative testing methods.

Main Results:

• The FDA's safety evaluation process is science-based and has successfully protected human health.
• Regulatory authority has expanded to include broader product classes, safety, efficacy, reporting, and enforcement.
• FDA actively promotes the prioritization, standardization, validation, and globalization of testing strategies.
• The agency champions alternative methods to reduce and replace animal testing, aiming for comparable or superior data.

Conclusions:

• The FDA's regulatory framework, supported by research and evolving methodologies, is crucial for public health protection.
• Scientific and technological advancements present opportunities to enhance toxicological practices through validated alternative methods.
• The FDA plays a key role in advancing regulatory science and promoting ethical, effective testing strategies.